Tegoyes 15MG Capsule (7’s) is a combination medication primarily used in the treatment of certain types of cancer, particularly gastric cancer. This capsule contains three active ingredients: Gimeracil (5.8mg), Oteracil (15.8mg), and Tegafur (20mg). Gimeracil is known for its ability to inhibit the enzyme dihydropyrimidine dehydrogenase, which is involved in the metabolism of fluorouracil, enhancing the effectiveness of cancer treatment. Oteracil works by reducing the gastrointestinal toxicity associated with Tegafur, a prodrug that is converted into fluorouracil in the body, thereby increasing its anti-cancer effects while minimizing side effects. Together, these components work synergistically to improve the therapeutic outcomes for patients undergoing chemotherapy. Tegoyes is typically prescribed as part of a comprehensive cancer treatment plan, and its formulation is designed to optimize the efficacy of chemotherapy while reducing adverse effects, making it a valuable option for patients battling cancer.